High ceftazidime hydrolysis activity and porin OmpK35 deficiency contribute to the decreased susceptibility to ceftazidime/avibactam in KPC-producing Klebsiella pneumoniae

In VitroSusceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014)

(2016) Boudewijn L. M. de Jonge et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Characterization of the genetic environment of the blaKPC-2 gene among Klebsiella pneumoniae isolates from a Chinese Hospital

(2016) Pinghua Shen et al.   Brazilian Journal of Infectious Diseases

First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate

(2015) Romney M. Humphries et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria

(2015) Xian-Zhi Li et al.   CLINICAL MICROBIOLOGY REVIEWS

Ceftolozane/tazobactam and ceftazidime/avibactam: two novel β-lactam/β-lactamase inhibitor combination agents for the treatment of resistant Gram-negative bacterial infections

(2015) Jordan L. Liscio et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Allocation of Klebsiella pneumoniae Bloodstream Isolates into Four Distinct Groups byompK36Typing in a Taiwanese University Hospital

(2015) Jing-Jou Yan et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Phenotypic and Molecular Characteristics of Carbapenem-Resistant Enterobacteriaceae in a Health Care System in Los Angeles, California, from 2011 to 2013

(2014) S. Pollett et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Contemporary Diversity of β-Lactamases among Enterobacteriaceae in the Nine U.S. Census Regions and Ceftazidime-Avibactam Activity Tested against Isolates Producing the Most Prevalent β-Lactamase Groups

(2013) Mariana Castanheira et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination

(2013) George G. Zhanel et al.   DRUGS

OmpK35 and OmpK36 porin variants associated with specific sequence types ofKlebsiella pneumoniae

(2013) Constantinos C Papagiannitsis et al.   JOURNAL OF CHEMOTHERAPY

Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

(2013) L Silvia Munoz-Price et al.   LANCET INFECTIOUS DISEASES

Carbapenem resistance in Enterobacteriaceae: here is the storm!

(2012) Patrice Nordmann et al.   TRENDS IN MOLECULAR MEDICINE

blaKPCRNA Expression Correlates with Two Transcriptional Start Sites but Not Always with Gene Copy Number in Four Genera of Gram-Negative Pathogens

(2011) Amanda L. Roth et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

High Prevalence of KPC-2-Type Carbapenemase Coupled with CTX-M-Type Extended-Spectrum β-Lactamases in Carbapenem-Resistant Klebsiella pneumoniae in a Teaching Hospital in China

(2011) Shudan Chen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prevalence and Characteristics of Ertapenem-Resistant Klebsiella pneumoniae Isolates in a Taiwanese University Hospital

(2011) Jiunn-Jong Wu et al.   Microbial Drug Resistance

Activities of NXL104 Combinations with Ceftazidime and Aztreonam against Carbapenemase-ProducingEnterobacteriaceae

(2010) David M. Livermore et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Genetic Factors Associated with Elevated Carbapenem Resistance in KPC-Producing Klebsiella pneumoniae

(2010) B. Kitchel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China

(2010) Yan Qi et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae

(2010) Caroline Dallenne et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK

(2009) M. Doumith et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Extended-spectrum β-lactamases and the permeability barrier

(2008) L. Martínez-Martínez   CLINICAL MICROBIOLOGY AND INFECTION